| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jorge Morales-Montor | |
| Mariana Segovia-Mendoza | |||
| P2860 | cites work | Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells | Q24296874 |
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| The effect of estrogens on superoxide anion generation by human neutrophil granulocytes: possible consequences of the antioxidant defense | Q81243414 | ||
| Alternative activation of human macrophages is rescued by estrogen treatment in vitro and impaired by menopausal status | Q85746566 | ||
| Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting | Q26742012 | ||
| The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases | Q26752888 | ||
| The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases | Q26771457 | ||
| Mast Cell: A Multi-Functional Master Cell | Q26771463 | ||
| Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease | Q27015076 | ||
| Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation | Q27315026 | ||
| Molecular Classification of Triple-Negative Breast Cancer | Q28076661 | ||
| Estrogen receptor phosphorylation | Q28217134 | ||
| Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells | Q28285887 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways | Q28350521 | ||
| Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus | Q28366004 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Functions of natural killer cells | Q29614300 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN | Q29619346 | ||
| Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution | Q33587378 | ||
| Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. | Q33597501 | ||
| The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment. | Q33607142 | ||
| Bisphenol A at concentrations relevant to human exposure enhances histamine and cysteinyl leukotriene release from bone marrow-derived mast cells | Q33648497 | ||
| Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro | Q33784120 | ||
| NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study | Q34132372 | ||
| The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients | Q34348172 | ||
| Estrogen enhances immunoglobulin production by human PBMCs | Q34491431 | ||
| Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
| Structure-function relationship of estrogen receptor alpha and beta: impact on human health | Q34558007 | ||
| Estrogen alters thresholds for B cell apoptosis and activation | Q34792410 | ||
| CD4 T cells: fates, functions, and faults | Q34813153 | ||
| The role of cytokines in breast cancer development and progression | Q34920381 | ||
| Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer. | Q35009369 | ||
| Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer | Q35182981 | ||
| Estrogen receptors regulate innate immune cells and signaling pathways | Q35236340 | ||
| Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells | Q40364697 | ||
| Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group | Q40386096 | ||
| The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation | Q40388357 | ||
| 17-Beta estradiol enhances prostaglandin E2 production in human U937-derived macrophages | Q40494503 | ||
| Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells | Q40533988 | ||
| Expression of iNOS gene in macrophages stimulated with 17beta-estradiol is regulated by free intracellular Ca2+. | Q40548548 | ||
| An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. | Q40549904 | ||
| Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. | Q40630820 | ||
| Effect of estrogen on natural killer cells | Q41129214 | ||
| Presence of oestrogen receptors in human blood mononuclear cells and thymocytes | Q41446896 | ||
| A single neonatal administration of Bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood | Q41620366 | ||
| Heterogeneity in breast cancer | Q42942060 | ||
| Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma | Q43159823 | ||
| Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids | Q43589371 | ||
| Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus | Q43619904 | ||
| The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. | Q43687769 | ||
| Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy | Q43756073 | ||
| Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol | Q43766101 | ||
| Estrogen receptors in mast cells from arterial walls. | Q44023327 | ||
| Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: regulation by estrogen | Q44140908 | ||
| Estrogen inhibition of EAE involves effects on dendritic cell function. | Q44149897 | ||
| Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes | Q44259071 | ||
| Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors | Q44280459 | ||
| Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone | Q44468877 | ||
| Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. | Q44504634 | ||
| Beta-estradiol-induced decrease in IL-12 and TNF-alpha expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice | Q44542561 | ||
| Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype | Q44576030 | ||
| Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. | Q44585173 | ||
| Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients | Q44817903 | ||
| 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells | Q44895752 | ||
| Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma | Q44915098 | ||
| 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages | Q44930041 | ||
| Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment | Q45007526 | ||
| A study on the effects of estradiol and estramustine on gastrointestinal cell lines | Q45244446 | ||
| Mechanisms of T regulatory cell function | Q37166838 | ||
| Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages | Q37182447 | ||
| Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer | Q37340362 | ||
| Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow | Q37373492 | ||
| The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation | Q37479270 | ||
| Natural antibodies and cancer | Q37482451 | ||
| Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis | Q37566328 | ||
| "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy | Q37697126 | ||
| Mechanism of immune evasion in breast cancer | Q37712385 | ||
| Estrogen receptors in immunity and autoimmunity. | Q37721297 | ||
| Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy | Q37740954 | ||
| Regulatory T cells and breast cancer: implications for immunopathogenesis | Q37787092 | ||
| Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer | Q37930487 | ||
| The multifaceted functions of neutrophils | Q38139589 | ||
| The immune system and response to HER2-targeted treatment in breast cancer | Q38183569 | ||
| Neutrophil-derived cytokines: facts beyond expression | Q38265504 | ||
| Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages | Q38266887 | ||
| Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Q38669465 | ||
| Priming of the neutrophil respiratory burst: role in host defense and inflammation. | Q38936526 | ||
| Regulation of HRG-β1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression | Q39350298 | ||
| Mast cells in breast cancer angiogenesis | Q39364825 | ||
| Oestrogen modulates human macrophage apoptosis via differential signalling through oestrogen receptor-alpha and beta | Q39742046 | ||
| Up-regulation of Bcl-2 through ERK phosphorylation is associated with human macrophage survival in an estrogen microenvironment | Q40098196 | ||
| Sex Differences in Macrophage Functions in Middle-Aged Rats: Relevance of Estradiol Level and Macrophage Estrogen Receptor Expression. | Q40269208 | ||
| Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function | Q40327418 | ||
| Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. | Q35404457 | ||
| Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation | Q35546707 | ||
| Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer | Q35580183 | ||
| Two types of human mast cells that have distinct neutral protease compositions | Q35611922 | ||
| Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators | Q35636241 | ||
| Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. | Q35698962 | ||
| International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators | Q35795751 | ||
| Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. | Q35889643 | ||
| Proinflammatory and anti-inflammatory cytokine changes related to menopause | Q35903575 | ||
| Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review). | Q35934485 | ||
| Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18). | Q35964527 | ||
| Role of female sex hormones, estradiol and progesterone, in mast cell behavior | Q36041383 | ||
| Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. | Q36160032 | ||
| Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide | Q36174776 | ||
| Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study | Q36222126 | ||
| Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice | Q36278726 | ||
| Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures | Q36345995 | ||
| B Cells, Antibodies, and More | Q36432935 | ||
| Biological role of NK cells and immunotherapeutic approaches in breast cancer | Q36460884 | ||
| Neutrophils: Their Role in Innate and Adaptive Immunity. | Q36666120 | ||
| Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity | Q36693276 | ||
| Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators | Q36721757 | ||
| Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. | Q36736233 | ||
| Neutrophil serine proteases fine-tune the inflammatory response | Q36737987 | ||
| The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions | Q36792231 | ||
| Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells | Q36796668 | ||
| Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer | Q36800215 | ||
| Overexpression of caspase 7 is ERα dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). | Q36846714 | ||
| PD-L1 Expression Is Associated with Tumor FOXP3(+) Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient | Q36882550 | ||
| Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment | Q37003317 | ||
| Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx | Q37015361 | ||
| The immune system and inflammation in breast cancer | Q37033451 | ||
| Macrophage polarization in tumour progression | Q37158140 | ||
| Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations | Q37163950 | ||
| Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. | Q45274056 | ||
| Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients | Q46136042 | ||
| Effect of estrogen and progesterone on macrophage activation during wound healing | Q46157697 | ||
| Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship | Q46267039 | ||
| Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation | Q46763975 | ||
| Estradiol attenuates lipopolysaccharide-induced CXC chemokine ligand 8 production by human peripheral blood monocytes. | Q46942108 | ||
| The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. | Q46954163 | ||
| Oestrogen Receptor-α binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer. | Q47129920 | ||
| Breast cancer genomics and immuno-oncological markers to guide immune therapies. | Q47859126 | ||
| The role of G protein-coupled receptors in lymphoid malignancies | Q47960121 | ||
| S-Glutathionylation of estrogen receptor alpha affects dendritic cell function. | Q49647245 | ||
| Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation | Q50275568 | ||
| Breast cancer as a global health concern. | Q50560105 | ||
| Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils. | Q50912572 | ||
| Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. | Q51809264 | ||
| Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. | Q51824795 | ||
| Estradiol induced alterations of the immune system--I. Enhancement of IgM production. | Q52208526 | ||
| Normal haematological values: sex difference in neutrophil count | Q52882803 | ||
| Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. | Q52907227 | ||
| CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer. | Q53534096 | ||
| Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen. | Q53802298 | ||
| Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. | Q54502028 | ||
| Recent Advances in the Treatment of Breast Cancer. | Q55353691 | ||
| Immune characterization of breast cancer metastases: prognostic implications. | Q55450758 | ||
| Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer. | Q55483878 | ||
| Starting the Fight in the Tumor: Expert Recommendations for the Development of Human Intratumoral Immunotherapy (HIT-IT) | Q57180378 | ||
| Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse | Q58211903 | ||
| Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: evidence for an estrogen surface receptor | Q58356705 | ||
| Estrogen Receptor-Alpha Promotes Alternative Macrophage Activation during Cutaneous Repair | Q60042087 | ||
| Serum immunoglobulins in women with breast cancer | Q66946165 | ||
| Oestradiol enhances in vitro the histamine release induced by embryonic histamine-releasing factor (EHRF) from uterine mast cells | Q67543457 | ||
| The influence of beta-estradiol and progesterone on interferon gamma production in vitro | Q68375635 | ||
| Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer | Q69397206 | ||
| Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes | Q69897572 | ||
| Natural killer cell activity and tumor susceptibility in female mice treated neonatally with diethylstilbestrol | Q70998474 | ||
| Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma | Q71614098 | ||
| L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin | Q71704996 | ||
| Effect of estrogen replacement therapy on natural killer cell activity in postmenopausal women | Q71940061 | ||
| Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation | Q72193108 | ||
| Natural killer cell activity is reduced in association with oral contraceptive use | Q72304242 | ||
| An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage | Q72358218 | ||
| Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations | Q73050444 | ||
| In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes | Q73186858 | ||
| 17 Beta-estradiol-stimulated nitric oxide production by neutrophils: effect on platelet activation | Q73448054 | ||
| Prognostic value of tumor-associated macrophage count in human bladder cancer | Q74052812 | ||
| Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival | Q74153839 | ||
| Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1) | Q79699846 | ||
| Induction of regulatory T cells by physiological level estrogen | Q80678123 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| tumor microenvironment | Q1786433 | ||
| breast neoplasm | Q23929670 | ||
| P304 | page(s) | 348 | |
| P577 | publication date | 2019-01-01 | |
| 2019-03-01 | |||
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogens and Its Receptors Into Cancer Physiopathology | |
| P478 | volume | 10 |
| Q103805662 | Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients |
| Q94599614 | Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment |
| Q92730933 | The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer |
| Q96342312 | The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors |
| Q99545599 | Zinc distribution within breast cancer tissue of different intrinsic subtypes |
Search more.